Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/48257
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Rico-Bautista, Elizabeth | en_US |
dc.contributor.author | Flores-Morales, Amilcar | en_US |
dc.contributor.author | Fernández-Pérez, Leandro | en_US |
dc.date.accessioned | 2018-11-23T20:12:29Z | - |
dc.date.available | 2018-11-23T20:12:29Z | - |
dc.date.issued | 2006 | en_US |
dc.identifier.issn | 1359-6101 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/48257 | - |
dc.description.abstract | Cytokine receptors act through a complex signaling network, involving Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs), to regulate diverse biological processes which control growth, development, homeostasis and immune function, among others. The JAK/STAT signaling pathway is attenuated via three mechanisms controlling the initiation, magnitude, and duration of the signal: the PIAS proteins. which prevent STAT dimerization or DNA interaction, the SHP phosphatases, which dephosphorylate activating tyrosine phosphorylations, and the suppressors of cytokine signaling (SOCS), which are transcribed in response to cytokine stimulation and use several interconnected mechanisms to downregulate the signal. Specific studies targeting the SOCS genes in vivo have unveiled SOCS2 as the main regulator of somatic growth through regulation of GH/IGF-1 signaling. In addition, several studies indicate that SOCS2 also has important actions in the central nervous system, the regulation of metabolism, the immune response, the mammary gland development, cancer, and other cytokine-dependent signaling pathways. Consistent with the role of cytokines in human physiology, any SOCS2 imbalance could result in a broad range of pathologies such as cardiovascular diseases, insulin resistance, cancer, and severe infections, among others. Thus, determining the importance of SOCS2 in health and disease will no doubt aid in the development of novel therapeutic strategies. In this review, we attempt to summarize the available information, including our results, regarding the role of SOCS2 in several biological processes. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Cytokine and Growth Factor Reviews | en_US |
dc.source | Cytokine and Growth Factor Reviews[ISSN 1359-6101],v. 17, p. 431-439 | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 2412 Inmunología | en_US |
dc.subject.other | Growth-Hormone Action | en_US |
dc.subject.other | Inducible Sh2-Containing Protein | en_US |
dc.subject.other | Ciliary Neurotrophic Factor | en_US |
dc.subject.other | Messenger-Ribonucleic-Acid | en_US |
dc.subject.other | Mammary-Gland Development | en_US |
dc.subject.other | Induced Stat Inhibitor | en_US |
dc.subject.other | Factor-I Receptor | en_US |
dc.subject.other | Negative Regulation | en_US |
dc.subject.other | Gene-Expression | en_US |
dc.subject.other | Socs Genes | en_US |
dc.title | Suppressor of cytokine signaling (SOCS) 2, a protein with multiple functions | en_US |
dc.type | info:eu-repo/semantics/annotation | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.cytogfr.2006.09.008 | en_US |
dc.identifier.scopus | 33751212182 | - |
dc.identifier.isi | 000243018900003 | - |
dc.contributor.authorscopusid | 6508139241 | - |
dc.contributor.authorscopusid | 57203543352 | - |
dc.contributor.authorscopusid | 6506777525 | - |
dc.description.lastpage | 439 | en_US |
dc.description.firstpage | 431 | en_US |
dc.relation.volume | 17 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Comentario | en_US |
dc.contributor.daisngid | 3599226 | - |
dc.contributor.daisngid | 617657 | - |
dc.contributor.daisngid | 795544 | - |
dc.description.numberofpages | 9 | en_US |
dc.utils.revision | Sí | en_US |
dc.contributor.wosstandard | WOS:Rico-Bautista, E | - |
dc.contributor.wosstandard | WOS:Flores-Morales, A | - |
dc.contributor.wosstandard | WOS:Fernandez-Perez, L | - |
dc.date.coverdate | Diciembre 2006 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | GIR IUIBS: Farmacología Molecular y Traslacional | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.orcid | 0000-0002-0828-8921 | - |
crisitem.author.orcid | 0000-0001-7802-465X | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Flores Morales,Amilcar | - |
crisitem.author.fullName | Fernández Pérez, Leandro Francisco | - |
Appears in Collections: | Comentario |
SCOPUSTM
Citations
164
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
162
checked on Nov 17, 2024
Page view(s)
66
checked on Jun 15, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.